Meyahealth
HomeGeneticsGeneRGS9 gene
Back to Gene
RGS9 gene
Reviewed by Medicinsk Expert•Last updated: 2026-10-22•Gene

RGS9 gene

The RGS9 gene produces proteins essential for visual processing in the retina and signaling pathways in the brain that coordinate movement.

Normal Function

The RGS9 gene provides instructions for making two versions (isoforms) of the RGS9 protein, known as RGS9-1 and RGS9-2. They are found in different parts of the nervous system and have very different functions.

RGS9-1 is produced in the retina, which is the specialized tissue at the back of the eye that detects light and color. Within the retina, RGS9-1 is associated with light-detecting cells called photoreceptors. When light enters the eye, it stimulates specialized pigments in these cells. This stimulation triggers a series of chemical reactions that produce an electrical signal, which is interpreted by the brain as vision (a process known as phototransduction). Once photoreceptors have been stimulated by light, they must return to their resting state before they can be stimulated again. RGS9-1 is involved in a chemical reaction that helps return photoreceptors to their resting state quickly after light exposure.

RGS9-2 is found primarily in an area deep within the brain called the striatum. Although its exact role is unknown, RGS9-2 appears to be part of signaling pathways involving a chemical messenger (neurotransmitter) called dopamine. These pathways are important for planning and coordinating movement. Studies suggest that RGS9-2 also plays a role in the brain's response to opioid drugs, such as morphine and cocaine.

Health Conditions Related to Genetic Changes

Bradyopsia

At least two mutations in the RGS9 gene have been found to cause bradyopsia, a rare condition that affects vision. In people with bradyopsia, the eyes adapt more slowly than usual to changing light conditions. Some affected individuals also have difficulty seeing small moving objects.

The RGS9 gene mutations that cause bradyopsia greatly reduce or eliminate the function of RGS9-1 in photoreceptors. A loss of RGS9-1 function prevents photoreceptors from recovering quickly after responding to light. Normally they return to their resting state in a fraction of a second, but in people with RGS9 gene mutations, it can take ten seconds or longer. During that time, the photoreceptors cannot respond to light. This delay causes temporary blindness in response to changing light conditions and may interfere with seeing small objects when they are in motion.

Other Names for This Gene

  • MGC111763
  • MGC26458
  • regulator of G-protein signaling 9
  • regulator of G-protein signalling 9
  • RGS9L

Frequently Asked Questions

RGS9‑related bradyopsia follows an autosomal recessive pattern. Both parents must carry one pathogenic allele; each pregnancy carries a 25 % risk of an affected child, a 50 % chance of a carrier, and a 25 % chance of an unaffected non‑carrier. Carrier testing for siblings and prenatal or pre‑implantation genetic testing are options for families planning more children.
Mutations in RGS9 impair the RGS9‑1 isoform that accelerates the deactivation of phototransduction cascade proteins in rod and cone cells. The result is prolonged recovery of photoreceptors after bright light, leading to delayed adjustment when moving between light and dark environments (bradyopsia). Diagnosis combines a detailed visual history, electroretinography showing delayed recovery kinetics, and molecular testing (targeted RGS9 sequencing or a retinal dystrophy panel).
No disease‑modifying therapy currently exists. Patients benefit from practical strategies: using sunglasses or tinted lenses to reduce glare, allowing extra time for visual transitions, and employing high‑contrast, large‑print materials. Low‑vision rehabilitation specialists can prescribe adaptive devices such as electronic magnifiers and contrast‑enhancing filters.
Because the condition primarily affects rapid light adaptation, patients should avoid occupations requiring sudden shifts between bright and dim environments (e.g., pilots, night‑time driving, certain manufacturing roles). If such work is unavoidable, accommodations like adjustable lighting, protective eyewear, and scheduled breaks to allow visual adaptation are recommended.
Source: MedlinePlus, National Library of Medicine

MedlinePlus brings together authoritative health information from the National Library of Medicine (NLM), the National Institutes of Health (NIH), and other government agencies and health-related organizations.

Meyahealth

Ⓒ 2026. All rights reserved by MEYA

About UsTerms & PolicyFAQ